A naturally new ester, 2,4-dichlorophenyl 2,4-dichloro benzoate (1) and a new compound, 4,5-dihydroxy-7-methylphthalide (2), along with eight known compounds were isolated from the fermentation broth of the marine-derived actinomycete Streptomyces sp. (strain G212). The structures of these compounds were established by their spectral data analysis, including MS, and 2D-NMR. To confirm the structures of the two new compounds 1 and 2, their total syntheses were achieved. These syntheses also allow obtaining enough quantities of 1 and 2 for their biological screening. The isolated compounds and synthetic samples were evaluated for their antimicrobial activity against a panel of clinically significant microorganisms. Except for 8 and 10, the remaining compounds were active against at least one tested microbial strain with the MIC values in range of 32-256 µg/mL. Compounds 5, 6, 17 and 2a were found to have a broad-spectrum of antimicrobial activity.
Marine bacteria have recently attracted the attention of many scientists as a potential source of producing structurally novel secondary metabolites [1, 2] , with a wide variety of biological activities, such as antimicrobial, antiviral and antitumor properties [3] . Among them, marine actinomycete has been a prolific source of specialized metabolites and the vast majority of these compounds are derived from the single genus Streptomyces [4] . This genus has an enormous biosynthetic potential that remains unchallenged without a potential competitor among other microbial groups [5] . The East Sea in Vietnam covers an area of approximately threemillion km 2 and has about more than 3,000 km of coastline that encompasses a multitude of microenvironments covering depths from 200 m to 5,000 m. The marine biodiversity of the East Sea is considered to be among the most extensive in the world, but remains poorly understood and explored.
In search of new antimicrobial metabolites from marine-derived actinomycetes, the EtOAc extract of Streptomyces sp. (strain G212) fermentation exhibited antibacterial activity against E. faecalis and B. cereus. In this communication, we report the purification of the EtOAc extract of the Streptomyces sp. (strain G212). In order to confirm the structures of two new metabolites 1 and 2, their syntheses were performed. The antimicrobial activity of the isolated compounds and selected synthetic structures were also discussed.
Culture broth (30 L) of the Streptomyces sp. (strain G212) was extracted with EtOAc (5 x 20 L). The organic solvent was combined and concentrated under reduced pressure. The residue (25.3 g) was purified by repeated open column chromatography to afford compounds 1 -10.
Compound 1 was isolated as a white solid. Its HR-ESI mass spectrum showed the proton adduct molecular ion [M+H] + at m/z 334.9194 (with chlorine isotopic pattern at m/z 334.9194, 336.9167, connection of the carbonyl group to the A-ring. The carbon chemical shift of C-1′ ( C 145.5) suggested its linkage to oxygen. Considering the molecular formula of C 13 H 6 Cl 4 O 2 established above, the structure of 1 was identified as 2,4-dichlorophenyl 2,4-dichlorobenzoate ( Figure 2 ). Since the ester linkage of the A-and B-ring could not be resolved by HMBC data analysis, the structure of 1 was then confirmed by a simple synthesis step which was achieved by reaction of 2,4-dichloro-benzoyl chloride (11) and 2,4-dichlorophenol (12) (Scheme 1). The reaction was carried-out at 0 o C to room temperature in the presence of Et 3 N. The 1 H NMR spectrum of the synthetic sample was identical with that of the natural compound 1 (S-16, Supporting Information). The compound 1 is commercially available, however, this is the first reported from a nature source.
Scheme 1: Synthesis of 1
Compound 2 was isolated as a white solid. The HR-ESI mass spectrum showed the proton adduct molecular ion [M+H] + at m/z 181.0496 which together with 13 C-NMR data, suggested a molecular formula of C 9 H 8 O 4 for 2. Its IR absorptions implied the presence of hydroxyl groups (3475 cm -1 ) and carbonyl functionality (1717 cm -1 ). The 1D NMR ( 1 H and 13 C) spectra of 2 showed one methyl group ( H 2.38,  C 16.0), one methylene ( H 5.13,  C 66.7), one sp 2 methine ( H 6.72,  C 118.4), five aromatic quaternary carbons ( C 113.5, 130.1, 134.7, 137.1 and 150.6), and one carbonyl carbon ( C 170.9). The six degrees of unsaturation were thus assigned to compound 2. The chemical shifts of CH 2 -3, C-4 and C-5 suggested their linkage to oxygen (Table 1) . Intensive analyses of the 2D NMR spectral data, especially the HMBC spectrum indicated that compound 2 was a phthalide derivative. However, the protons of CH 2 -3 ( H 5.13) were correlated to both C-4 ( C 137.1) and C-7 ( C 130.1) in the HMBC spectrum. Thus, one of these cross-peaks should be a four-bond long-range correlation. This observation suggested two structural possibilities for compound 2 ( Figure 3 ). To confirm the structure of 2 and to obtain enough quantity for biological assay, a total synthesis of 2 and its isomer 2a, was performed. As indicated in Scheme 2, the commercially available substance 2,3-dimethoxybenzoic acid (13) was used as starting material which was converted into phthalide derivative 14 using concentrated HCl and paraformaldehyde at 60 -70 o C [6] . In the next step, compound 14 was reduced by LiAlH 4 in THF at reflux to afford the alcohol 15 in 72% yield. Oxidation of 15 by KMnO 4 , yielding the phthalic anhydride derivative 16 which was then treated with LiAlH 4 to provide a mixture of two isomers 17 and 18 with a ratio of 2/1, respectively. The two isomers 17 and 18 were successfully separated by column chromatography and their structures were confirmed by NMR data analysis. In order to support for the structural distinction between the two isomers 17 and 18, compound 17 was also synthesized from the halogenated compound 14 by catalytic hydrogenation. Finally, exposure of 17 and 18 to BBr 3 in CH 2 Cl 2 afforded compounds 2a and 2, respectively. Comparison of NMR data of the natural sample 2 with those of two synthetic isomers, the structure of the natural compound 2 was identified as 4,5-dihydroxy-7-methylphthalide.
The known compounds, germicidin A (3) [7] , germicidin B (4) [8] , 5-hydroxymethyl-4-hydroxy-2,4-dimethyl-2-cyclopentenone (5) [9] 2'-deoxythymidine (6) [10] , 2′-deoxyuridine (7) [11] N-[2-(1H-indol-3-yl)-2-oxo-ethyl] acetamide (8) [12] , 3,4-dihydroxy-6,7-dimethyl-quinoline-2-carboxylic (9) [13] , and Cyclo-(Leu-Pro) (10) [14] , were also isolated and characterized from the culture broth of Streptomyces sp. G212 strain. Their structures were determined by spectral data analysis and comparison with those reported in the literature.
Natural compounds 1-10 and synthetic substances 17-18, 2a were evaluated for their antibacterial activity against Escherichia coli Antimicrobial metabolites from a marine Actinomycete Natural Product Communications Vol. 14 (1) 2019 123 (ATCC25922), Pseudomonas aeruginosa (ATCC7853), Salmonella enterica (ATCC12228), Enterococcus faecalis (ATCC13124), Staphylococcus aureus (ATCC25923), Bacillus cereus (ATCC13245), and antifungal activity against Candida albicans (ATCC1023). Streptomycin and cyclohexamide were used as reference compounds. Except two compounds 8 and 10, the other tested compounds had inhibition activity against at least one microbial strain (Table 2) . Compounds 5, 6, 17 and 2a displayed a broad-spectrum of antimicrobial activity. Additionally, the compound 5 has been previously reported from Streptomyces species [9] , however this is the first report for its antibacterial and antifungal activities. The new compound 2 was not active against the yeast strain (C. albicans) while its synthetic structural isomer 2a exhibited a remarkable inhibition toward C. albicans with a MIC value of 32 µg/mL. Germicidins A (3) and B (4) belong to an antibiotic group of natural products. This compound class is mainly found from Streptomyces species and acts as autoregulatory inhibitor of spore germination [15] . The discovery of germicidins A (3) and B (4) from the culture broth of Streptomyces sp. (strain G212) provided an additional source for production of these antibiotic germicidins. The two synthetic intermediates 17 and 18 showed lightly different inhibition properties comparing to their corresponding demethylated derivatives 2a and 2. This suggested that the methylation of the hydroxyl groups of 2 and 2a affected to their inhibition activity against several microbial strains.
Experimental
General: HR-ESI-MS were recorded on a FT-ICR 910-MS TQFTMS-7T and a VARIAN 910 mass spectrometers. IR spectra were recorded on a Nicolet Impact 410 FT-IR spectrometer, UV spectra measured on a UV-1601 spectrometer, and NMR spectra were recorded on a Bruker AM500 MHz spectrometer operating at 125.76 MHz for 13 C NMR, and at 500.13 MHz for 1 H-NMR. The HMBC measurements were optimized to 7.0 Hz long-range couplings.
Bacterial isolation:
The marine sediment was collected in Quang Binh -Vietnam in April 2016, by Prof. Do Cong Thung, Institute of Marine Environment and Resources -Vietnam Academy of Science and Technology (VAST). The sediment sample (0.5 g) was suspended in 4.5 mL of sterile distilled water, homogenized by vortexing for 1 min, and the suspension was treated using a wet-heat technique (60°C for 6 min). Next, 0.5 ml of this suspension was transferred to another 4.5 mL sterile distilled water and this step was repeated to set up a tenfold dilution series. At the final dilution step, aliquots of 50 μL of sample solution was spread on A1 medium (Table 1S , Supporting Information). Strain G212 was registered with GenBank code: MF187963 ( Figure 2S , Supporting Information).
Extraction and isolation:
The fermentation broth (30 L) was extracted with ethyl acetate (5 x 20 L). The combined ethyl acetate extracts were then concentrated under reduced pressure to give 25.3 g of crude extract. This extract was purified by column chromatography (CC) on silica gel, eluted with CH 2 Cl 2 /MeOH gradient to give 8 fractions. Fraction F1 (2.5 g) was subjected to CC on silica gel (n-hexane/EtOAc gradient, 0 to 100% EtOAC in nhexane) to give 4 subfractions. Subfraction F1.1 was then subjected to a LH-20 column, eluting with MeOH to afford compound 1 (13.4 mg, R f 0.6, n-hexane/EtOAc: 9/1). Fraction F2 (1.5 g) was separated by CC on silica gel (CH 2 Cl 2 /EtOAc gradient, 0 to 100% EtOAC in n-hexane) to provide 4 sub-fractions. Sub-fraction F2.2 (650 mg) was purified on a LH-20 column using MeOH as eluent solvent to give compound 2 (8 mg, R f 0.7, CH 2 Cl 2 /MeOH: 9/1), compound 3 (4.8 mg, R f 0.65, CH 2 Cl 2 /MeOH: 9.5/0.5) and compound 9 (16 mg, R f 0.45, CH 2 Cl 2 /MeOH: 8.5/1.5). Sub-fraction F2.2.2 (27 mg) was purified by preparative TLC (CH 2 Cl 2 /EtOAc: 6/1) to afford compound 4 (10 mg, R f 0.55, n-hexane/EtOAc: 7/3) and compound 5 (6 mg, R f 0.75, CH 2 Cl 2 /MeOH: 9/1). Fraction F4 (13 g) was chromatographed on a silica gel column (CH 2 Cl 2 /MeOH gradient, 0 to 100% MeOH in CH 2 Cl 2 ) to provide 4 sub-fractions. Subfraction F4.2 (900 mg) was separated by Sephadex LH-20 (CH 2 Cl 2 /MeOH: 1/9) to give compound 6 (20 mg, R f 0.65, CH 2 Cl 2 /MeOH: 8.5/1.5) and compound 7 (10 mg, R f 0.6, CH 2 Cl 2 /MeOH: 8.5/1.5). Fraction F5 (650 mg) was chromatographed on silica gel column, eluted with
